Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019
In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. This report also discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets.
The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.
During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.
The major players in the metabolomics market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria). Collectively, the top five players accounted for nearly 75% of the global metabolomics market in 2013.
Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.
Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.
This report provides insights on the following pointers:
The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.
During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.
The major players in the metabolomics market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria). Collectively, the top five players accounted for nearly 75% of the global metabolomics market in 2013.
Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.
Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the metabolomics market. The report analyzes the metabolomics market by technique, application, and indication across all regions.
- Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the metabolomics market.
- Market Development: Comprehensive information on the lucrative emerging markets by technique, application, indication, and geography.
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the metabolomics market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the metabolomics market.
1 INTRODUCTION
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size Estimation
1.5.2 Market crackdown and Data Triangulation
1.5.3 Market Forecasting Model
1.5.4 Key Data Point Taken from Secondary Sources
1.5.5 Key Data Point Taken from Primary Sources
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
4 TECHNOLOGY INVESTMENT POTENTIAL
4.1 Introduction
4.2 Investment Client Networks
4.3 Funding Bodies
4.4 Funding Opportunities
4.5 Analysis of Potential Areas for Technology Investment using Strategic Evaluation
4.5.1 Parameters Considered for Emerging Opportunity Evaluation
4.5.2 Opportunity Strategic Evaluation Analysis
4.5.3 Description of Opportunities
5 MARKET OVERVIEW
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Research Funding and government support spurs the growth of this market
5.3.1.2 Biotechnology & Pharmaceutical Sectors Drive Metabolomics Research
5.3.1.3 Increasing demand for personalized medicine in healthcare industry
5.3.1.4 Increased Necessity for Toxicity Technologies
5.3.2 Restrains
5.3.2.1 Complexity in Data Processing & Analysis
5.3.2.2 Low Adoption Rate of Metabolomics Technologies
5.3.3 Opportunities
5.3.3.1 Untapped Emerging Market
5.3.3.2 Biomarker Discovery Services
5.3.4 Trends
5.3.4.1 Technological Advancements
5.3.4.2 Collaborations Between Research Universities and Market Players
6 MARKET SHARE ANALYSIS
7 — METABOLOMICS MARKET, BY TECHNIQUE
7.1 Introduction
7.2 Separation Techniques
7.2.1 Gas Chromatography (GC)
7.2.2 Ultra Performance Liquid Chromatography (UPLC)
7.2.3 High Performance Liquid Chromatography (HPLC)
7.2.4 Capillary Electrophoresis (CE)
7.3 Detection Techniques
7.3.1 Mass Spectrometry (MS)
7.3.2 Nuclear Magnetic Resonance Spectroscopy (NMR)
7.3.3 Surface Based Mass Analysis
8 — METABOLOMICS MARKET, BY APPLICATION
8.1 Introduction
8.2 Biomarker Discovery
8.3 Drug Discovery/Drug Assessment
8.4 Toxicity Assessment/Toxicology
8.5 Nutrigenomics
8.6 Others
9 — METABOLOMICS MARKET, BY INDICATION
9.1 Introduction
9.2 Oncology
9.3 Cardiology
9.4 Neurology
9.5 Others
10 — METABOLOMICS MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoA
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.2 Latin America
11 COMPETITIVE LANDSCAPE
11.1 Introduction
11.2 New Product Launches
11.3 Expansions
11.4 Acquisitions
11.5 Agreements, Partnerships, and Collaborations
11.6 Product Enhancements
12 COMPANY PROFILES
12.1 Agilent Technologies
12.2 Biocrates Life Sciences AG
12.3 Bruker Corporation
12.4 Danaher Corporation
12.5 Human Metabolomics Technologies, Inc.
12.6 LECO Corporation
12.7 Metabolon, Inc.
12.8 Shimadzu Corporation
12.9 Thermo Fisher Scientific, Inc.
12.10 Waters Corporation
13 APPENDIX
1.1 Key Take-Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size Estimation
1.5.2 Market crackdown and Data Triangulation
1.5.3 Market Forecasting Model
1.5.4 Key Data Point Taken from Secondary Sources
1.5.5 Key Data Point Taken from Primary Sources
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
4 TECHNOLOGY INVESTMENT POTENTIAL
4.1 Introduction
4.2 Investment Client Networks
4.3 Funding Bodies
4.4 Funding Opportunities
4.5 Analysis of Potential Areas for Technology Investment using Strategic Evaluation
4.5.1 Parameters Considered for Emerging Opportunity Evaluation
4.5.2 Opportunity Strategic Evaluation Analysis
4.5.3 Description of Opportunities
5 MARKET OVERVIEW
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Research Funding and government support spurs the growth of this market
5.3.1.2 Biotechnology & Pharmaceutical Sectors Drive Metabolomics Research
5.3.1.3 Increasing demand for personalized medicine in healthcare industry
5.3.1.4 Increased Necessity for Toxicity Technologies
5.3.2 Restrains
5.3.2.1 Complexity in Data Processing & Analysis
5.3.2.2 Low Adoption Rate of Metabolomics Technologies
5.3.3 Opportunities
5.3.3.1 Untapped Emerging Market
5.3.3.2 Biomarker Discovery Services
5.3.4 Trends
5.3.4.1 Technological Advancements
5.3.4.2 Collaborations Between Research Universities and Market Players
6 MARKET SHARE ANALYSIS
7 — METABOLOMICS MARKET, BY TECHNIQUE
7.1 Introduction
7.2 Separation Techniques
7.2.1 Gas Chromatography (GC)
7.2.2 Ultra Performance Liquid Chromatography (UPLC)
7.2.3 High Performance Liquid Chromatography (HPLC)
7.2.4 Capillary Electrophoresis (CE)
7.3 Detection Techniques
7.3.1 Mass Spectrometry (MS)
7.3.2 Nuclear Magnetic Resonance Spectroscopy (NMR)
7.3.3 Surface Based Mass Analysis
8 — METABOLOMICS MARKET, BY APPLICATION
8.1 Introduction
8.2 Biomarker Discovery
8.3 Drug Discovery/Drug Assessment
8.4 Toxicity Assessment/Toxicology
8.5 Nutrigenomics
8.6 Others
9 — METABOLOMICS MARKET, BY INDICATION
9.1 Introduction
9.2 Oncology
9.3 Cardiology
9.4 Neurology
9.5 Others
10 — METABOLOMICS MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 RoE
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 RoA
10.5 Rest of the World (RoW)
10.5.1 Middle East
10.5.2 Latin America
11 COMPETITIVE LANDSCAPE
11.1 Introduction
11.2 New Product Launches
11.3 Expansions
11.4 Acquisitions
11.5 Agreements, Partnerships, and Collaborations
11.6 Product Enhancements
12 COMPANY PROFILES
12.1 Agilent Technologies
12.2 Biocrates Life Sciences AG
12.3 Bruker Corporation
12.4 Danaher Corporation
12.5 Human Metabolomics Technologies, Inc.
12.6 LECO Corporation
12.7 Metabolon, Inc.
12.8 Shimadzu Corporation
12.9 Thermo Fisher Scientific, Inc.
12.10 Waters Corporation
13 APPENDIX
LIST OF TABLES
Table 1 Global Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 2 Global Metabolomics Technique Market , By Country/Region, 2012–2019 ($Million)
Table 3 Global Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 4 Global Metabolomics Market For Seperation Technique, By Country/Region, 2012–2019 ($Million)
Table 5 Global Metabolomics Market For Gas Chromatography, By Country/Region, 2012–2019 ($Million)
Table 6 Global Ultra Performance Liquid Chromatography Market , By Country/Region, 2012–2019 ($Million)
Table 7 Global Metabolomics Market High Performance Liquid Chromatography, By Country/Region, 2012–2019 ($Million)
Table 8 Global Metabolomics Market For Capillary Electrophoresis, By Country/Region, 2012–2019 ($Million)
Table 9 Global Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 10 Global Metabolomics Market For Detection Technique, By Country/Region, 2012–2019 ($Million)
Table 11 Global Metabolomics Market for Mass Spectrometry, By Country/Region, 2012–2019 ($Million)
Table 12 Global Metabolomics Market For Nuclear Magnetic Resonance Spectroscopy, By Country/Region, 2012–2019 ($Million)
Table 13 Global Metabolomics Market For Surface Based Mass Analysis, By Country/Region, 2012–2019 ($Million)
Table 14 Global Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 15 Global Metabolomics Market For Biomarker Discovery Application, By Country/Region, 2012–2019 ($Million)
Table 16 Global Metabolomics Market For Drug Discovery Application, By Country/Region, 2012–2019 ($Million)
Table 17 Global Metabolomics Market For Toxicology Testing Application, By Country/Region, 2012–2019 ($Million)
Table 18 Global Metabolomics Market For Nutrigenomics Application, By Country/Region, 2012–2019 ($Million)
Table 19 Global Metabolomics Market For Other Applications, By Country/Region, 2012–2019 ($Million)
Table 20 Global Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 21 Global Metabolomics Market For Oncology Indication, By Country/Region, 2012–2019 ($Million)
Table 22 Global Metabolomics Market For Cardiology Indication, By Country/Region, 2012–2019 ($Million)
Table 23 Global Metabolomics Market For Neurology Indication, By Country/Region, 2012–2019 ($Million)
Table 24 Global Metabolomics Market For Other Indications, By Country/Region, 2012–2019 ($Million)
Table 25 Global Metabolomics Market Size, By Region, 2012–2019 ($Million)
Table 26 North America: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 27 North America: Metabolomics Market Size, By Country, 2012–2019 ($Million)
Table 28 North America: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 29 North America: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 30 North America: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 31 North America: Metabolomics Market, By Indication, 2012–2019 ($Million)
Table 32 U.S.: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 33 U.S.: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 34 U.S.: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 35 U.S.: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 36 U.S.: Metabolomics Market Size, By Indication , 2012–2019 ($Million)
Table 37 Canada: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 38 Canada: Metabolomics Marke Sizet, By Application, 2012–2019 ($Million)
Table 39 Canada: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 40 Canada: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 41 Canada: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 42 Europe: Metabolomics Market Size, By Country/Region, 2012–2019 ($Million)
Table 43 Europe: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 44 Europe: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 45 Europe: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 46 Europe: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 47 Europe: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 48 U.K.: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 49 U.K.: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 50 U.K.: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 51 U.K.: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 52 U.K.: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 53 Germany: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 54 Germany: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 55 Germany: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 56 Germany: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 57 Germany: Metabolomics Market Size, By Indication, 2012-2019 ($Million)
Table 58 France Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 59 France: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 60 France: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 61 France: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 62 France: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 63 Italy Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 64 Italy: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 65 Italy: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 66 Italy Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 67 Italy: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 68 Spain Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 69 Spain: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 70 Spain: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 71 Spain: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 72 Spain: Metabolomics Market, By Indication, 2012- 2019 ($Million)
Table 73 RoE: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 74 RoE: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 75 RoE: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 76 RoE: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 77 RoE: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 78 APAC: Metabolomics Market Size, By Country , 2012- 2019 ($Million)
Table 79 APAC: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 80 APAC: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 81 APAC: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 82 APAC: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 83 APAC: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 84 Japan: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 85 Japan: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 86 Japan: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 87 Japan: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 88 Japan: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 89 China: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 90 China: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 91 China: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 92 China: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 93 China: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 94 India: Metabolomics Market, By Technique, 2012- 2019 ($Million)
Table 95 India: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 96 India: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 97 India: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 98 India: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 99 RoA: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 100 RoA: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 101 RoA: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 102 RoA: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 103 RoA: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 104 RoW: Metabolomics Market Size, By Country/Region, 2012- 2019 ($Million)
Table 105 RoW: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 106 RoW: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 107 RoW: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 108 RoW: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 109 RoW: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 110 Middle East: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 111 Middle East: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 112 Middle East: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 113 Middle East: Metabolomics Market Size, By Application , 2012- 2019 ($Million)
Table 114 Middle East: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 115 Latin America: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 116 Latin America: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 117 Latin America: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 118 Latin America: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 119 Latin America: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 1 Global Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 2 Global Metabolomics Technique Market , By Country/Region, 2012–2019 ($Million)
Table 3 Global Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 4 Global Metabolomics Market For Seperation Technique, By Country/Region, 2012–2019 ($Million)
Table 5 Global Metabolomics Market For Gas Chromatography, By Country/Region, 2012–2019 ($Million)
Table 6 Global Ultra Performance Liquid Chromatography Market , By Country/Region, 2012–2019 ($Million)
Table 7 Global Metabolomics Market High Performance Liquid Chromatography, By Country/Region, 2012–2019 ($Million)
Table 8 Global Metabolomics Market For Capillary Electrophoresis, By Country/Region, 2012–2019 ($Million)
Table 9 Global Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 10 Global Metabolomics Market For Detection Technique, By Country/Region, 2012–2019 ($Million)
Table 11 Global Metabolomics Market for Mass Spectrometry, By Country/Region, 2012–2019 ($Million)
Table 12 Global Metabolomics Market For Nuclear Magnetic Resonance Spectroscopy, By Country/Region, 2012–2019 ($Million)
Table 13 Global Metabolomics Market For Surface Based Mass Analysis, By Country/Region, 2012–2019 ($Million)
Table 14 Global Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 15 Global Metabolomics Market For Biomarker Discovery Application, By Country/Region, 2012–2019 ($Million)
Table 16 Global Metabolomics Market For Drug Discovery Application, By Country/Region, 2012–2019 ($Million)
Table 17 Global Metabolomics Market For Toxicology Testing Application, By Country/Region, 2012–2019 ($Million)
Table 18 Global Metabolomics Market For Nutrigenomics Application, By Country/Region, 2012–2019 ($Million)
Table 19 Global Metabolomics Market For Other Applications, By Country/Region, 2012–2019 ($Million)
Table 20 Global Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 21 Global Metabolomics Market For Oncology Indication, By Country/Region, 2012–2019 ($Million)
Table 22 Global Metabolomics Market For Cardiology Indication, By Country/Region, 2012–2019 ($Million)
Table 23 Global Metabolomics Market For Neurology Indication, By Country/Region, 2012–2019 ($Million)
Table 24 Global Metabolomics Market For Other Indications, By Country/Region, 2012–2019 ($Million)
Table 25 Global Metabolomics Market Size, By Region, 2012–2019 ($Million)
Table 26 North America: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 27 North America: Metabolomics Market Size, By Country, 2012–2019 ($Million)
Table 28 North America: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 29 North America: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 30 North America: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 31 North America: Metabolomics Market, By Indication, 2012–2019 ($Million)
Table 32 U.S.: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 33 U.S.: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 34 U.S.: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 35 U.S.: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 36 U.S.: Metabolomics Market Size, By Indication , 2012–2019 ($Million)
Table 37 Canada: Metabolomics Market Size, By Technique, 2012–2019 ($Million)
Table 38 Canada: Metabolomics Marke Sizet, By Application, 2012–2019 ($Million)
Table 39 Canada: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 40 Canada: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 41 Canada: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 42 Europe: Metabolomics Market Size, By Country/Region, 2012–2019 ($Million)
Table 43 Europe: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 44 Europe: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 45 Europe: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 46 Europe: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 47 Europe: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 48 U.K.: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 49 U.K.: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 50 U.K.: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 51 U.K.: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 52 U.K.: Metabolomics Market Size, By Indication, 2012–2019 ($Million)
Table 53 Germany: Metabolomics Market Size, By Technique , 2012–2019 ($Million)
Table 54 Germany: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 55 Germany: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 56 Germany: Metabolomics Market Size, By Application, 2012–2019 ($Million)
Table 57 Germany: Metabolomics Market Size, By Indication, 2012-2019 ($Million)
Table 58 France Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 59 France: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 60 France: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 61 France: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 62 France: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 63 Italy Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 64 Italy: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 65 Italy: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 66 Italy Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 67 Italy: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 68 Spain Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 69 Spain: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 70 Spain: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 71 Spain: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 72 Spain: Metabolomics Market, By Indication, 2012- 2019 ($Million)
Table 73 RoE: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 74 RoE: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 75 RoE: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 76 RoE: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 77 RoE: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 78 APAC: Metabolomics Market Size, By Country , 2012- 2019 ($Million)
Table 79 APAC: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 80 APAC: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 81 APAC: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 82 APAC: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 83 APAC: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 84 Japan: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 85 Japan: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 86 Japan: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 87 Japan: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 88 Japan: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 89 China: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 90 China: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 91 China: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 92 China: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 93 China: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 94 India: Metabolomics Market, By Technique, 2012- 2019 ($Million)
Table 95 India: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 96 India: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 97 India: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 98 India: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 99 RoA: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 100 RoA: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 101 RoA: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 102 RoA: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 103 RoA: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 104 RoW: Metabolomics Market Size, By Country/Region, 2012- 2019 ($Million)
Table 105 RoW: Metabolomics Market Size, By Technique, 2012- 2019 ($Million)
Table 106 RoW: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 107 RoW: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 108 RoW: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 109 RoW: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 110 Middle East: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 111 Middle East: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 112 Middle East: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 113 Middle East: Metabolomics Market Size, By Application , 2012- 2019 ($Million)
Table 114 Middle East: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Table 115 Latin America: Metabolomics Market Size, By Technique , 2012- 2019 ($Million)
Table 116 Latin America: Metabolomics Market For Seperation Technique, By Product, 2012–2019 ($Million)
Table 117 Latin America: Metabolomics Market For Detection Technique, By Product, 2012–2019 ($Million)
Table 118 Latin America: Metabolomics Market Size, By Application, 2012- 2019 ($Million)
Table 119 Latin America: Metabolomics Market Size, By Indication, 2012- 2019 ($Million)
Metabolomics is the science of studying chemical processes concerning metabolites. It involves the use of various analytical techniques such as chromatography, spectrometry, nuclear magnetic resonance, and capillary electrophoresis. Metabolomic techniques generate a large amount of complex data which requires data processing and analysis software, and other bioinformatics tools. The development of these advanced tools and equipment is the primary reason for the rapid growth of metabolomics. Metabolomics is being used extensively in pharmaceutical and biotechnology industries for biomarker and drug discovery.
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent.
In addition to structural market drivers, there are strong geographic drivers for the growth of the metabolomics market. The European market is increasingly becoming the growth center for the global metabolomics market. This market is slated to witness significant growth during the forecast period of 2014 to 2019. The metabolomics market in the U.K. is slated to grow at a high CARG, which is mainly attributed to the active support and collaboration between major companies and the increasing number of academic and research institutes in this region. The Japanese market is a promising region for metabolomics companies, as a high amount of metabolomics research is being conducted in the country.
In 2013, North America dominated the market with a share of XX%, followed by Europe with a share of XX%. The presence of a large number of analytical equipment manufacturers has led to the large market share of the North American and European metabolomics markets. The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Biocrates Life Science AG (Austria), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).
